期刊文献+

四个生产来源血清β_(2)微球蛋白试剂的检测性能评价 被引量:1

Evaluation of the detection performance of serumβ_(2)-MG reagents of different manufacturers
下载PDF
导出
摘要 目的:评价4个厂家4种血清β_(2)微球蛋白(β_(2)-MG)试剂的检测性能。方法:选取医院收治的肾病患者及同期健康体检者血清制备混合血清。依据北京市临床检验中心对β_(2)-MG项目的管理要求、美国临床和实验室标准协会(CLSI’88)关于β_(2)-MG项目的管理要求,对北京九强生物技术股份有限公司(简称A试剂)、北京莱帮生物技术有限公司(简称B试剂)、重庆中元生物技术有限公司(简称C试剂)及奥地利DIALAB有限公司(简称D试剂)4个厂家的4种血清β_(2)-MG试剂进行性能评价。结果:4种β_(2)-MG试剂测定高低值混合样本的批内精密度均小于国家卫生健康委临床检验中心(NCCL)1/4允许偏差(7.5%),总精密度均<1/3允许偏差(10%)。4种试剂测定不同批次的具有溯源性的校准品样本,A试剂、B试剂、C试剂和D试剂测定值与认证值的平均偏倚均<1/2允许偏差(±15%)。验证4种试剂的线性范围和参考区间,线性范围:A试剂(0.26~48.73 mg/L),B试剂(0.05~18.65 mg/L),C试剂(0.25~65.34 mg/L),D试剂(0.09~53.95 mg/L);参考区间:A试剂(0.8~1.8 mg/L),B试剂(0~3.0 mg/L),C试剂(0.8~2.8 mg/L),D试剂(0.8~2.8 mg/L)。干扰物质胆红素、血红蛋白及乳糜对4种试剂的影响均在可接受范围内。4种试剂的携带污染率均符合要求,其中A试剂、B试剂和C试剂3种试剂携带污染率均为0,D试剂为0.31%。结论:4个厂家的4种β_(2)-MG试剂的精密度、正确度、抗干扰能力和携带污染率均可满足临床使用要求,且差异不大。线性范围和参考区间也验证通过,B试剂线性范围较窄,C试剂线性上限较高。 Objective:To evaluate the detection performance of four kinds of serumβ_(2)-microglobulin(β_(2)-MG)reagents from 4 manufacturers.Methods:Mixed serum was prepared from patients with kidney disease admitted to hospital and from healthy people who underwent physical examination in the same period.According to the requirements of Beijing Center for Clinical Laboratory onβ_(2)-MG item and the management requirements of clinical and laboratory standards institute(CLSI'88)aboutβ_(2)-MG item,the performances of serumβ_(2)-MG reagents from Beijing Strong Biotechnologies,Inc.("A reagent"),Beijing Labo Biotech,CO.,LTD.("B reagent"),Chongqing Zhongyuan Biological Technology co.,LTD.("C reagent")and the Austrian DIALAB Co.,LTD.("D reagent")were evaluated,respectively.Results:The within-run precisions of high and low values of mixed samples of 4 kinds ofβ_(2)-MG reagents were less than 1/4 allowable deviation(7.5%)of National Center for Clinical Laboratories(NCCL)of National Health Commission,and the total precisions of them were less than 1/3 allowable deviation(10%).The results that 4 kinds of reagents determined calibration samples with traceability of different batches indicated that the average bias between the measured value of each reagent and authentication value was less than 1/2 allowable deviation(±15%).The verified results of linearity range and reference interval indicated that the linearity ranges of 4 kinds of reagents respectively were(0.26~48.73)mg/L(A reagent),(0.05~18.65)mg/L(B reagent),(0.25~65.34)mg/L(C reagent)and(0.09~53.95)mg/L(D reagent),and the reference intervals of them respectively were(0.8~1.8)mg/L(A reagent),(0~3.0)mg/L(B reagent),(0.8~2.8)mg/L(C reagent)and(0.8~2.8)mg/L(D reagent).The influences of interfering substances included bilirubin,hemoglobin and chylus were within tolerance interval on 4 kinds of reagents.The carryover rates of 4 kinds of reagents could meet the requirement,and those of A reagent,B reagent and C reagent were 0,and that of reagent D was 0.31%.Conclusion:The precisions,accuracies,anti-interference abilities and carryover rates of 4 kinds ofβ_(2)-MG reagents from 4 manufacturers can meet the requirements of clinical use,and the differences of them are small.The linear range and reference interval of them pass the verification,and the linear range of B reagent is narrower,and the upper limit of linear range of C reagent is higher.
作者 董磊 全首祯 巩蓓 梁佩 李偌铱 丁巳娟 张谨 马红雨 马越云 DONG Lei;QUAN Shou-zhen;GONG Bei(Department of Clinical Laboratory,Air Force Medical Center,PLA,Beijing 100142,China)
出处 《中国医学装备》 2021年第9期16-19,共4页 China Medical Equipment
基金 国家重点研发计划(2019YFF0216502)“国家质量基础的共性技术研究与应用”。
关键词 血清β_(2)微球蛋白(β_(2)-MG) 试剂性能 肾小球滤过率 评价 Serumβ_(2)-microglobulin(β_(2)-MG) Reagent performance Glomerular filtration rate Evaluation
  • 相关文献

二级参考文献53

  • 1周青霞.胱抑素C、尿β2微球蛋白在老年糖尿病患者早期肾损伤临床监测应用[J].中国老年学杂志,2014,34(2):528-529. 被引量:16
  • 2王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 3梅长林,叶朝阳.实用透析手册[M].2版.北京:人民出版社,2009:282-288.
  • 4Miyata T,Oda O,Inagi R,et al. 2-microglobin modified with advanced glycation end products is a major component of hemodialysis as sociated amyloidosis[J]. J Clin Invest, 1993,92(3): 1243-1252.
  • 5张天民.超纯水对维持性血液透析患者炎症因子及B2-微球蛋白的影响[J].健康必读,2013,12(8):123.
  • 6Floege J,Ketteler M. 1 2-microglobulin-derived amyloidosis:an update[J]. Kidney Int, 2001 (Suppl 78):164 171.
  • 7Gejyo F,Yamada T,Odani S,et al.A new form of amyloid protein associated with chronic hemodialysis was identi-fied as beta 2-microglobulin[J].Biochem Biophys Res Commun, 1985,129(3): 701-706.
  • 8Dember LM,Jaber BL.Dialysis-Related Amylo- idosis:Late Finding or Hidden Epidemic?[J]. Seminars in Dialysis, 2006,19(2).. 105-109.
  • 9Cheung AK,Rocco MV,Yan G,et al.Serum 2-microglobulin levels predict mortality in dialysis patients: results of the HEMO study[J]. J Am Soc Nephrol, 2006,17(2) : 546 555.
  • 10Okuno S,Ishimura E,Kohno K,et al.Serum B 2-microglobulin level is a significant predictor of mortality in mainte-nance haemodialysis patients[J]. Nephrol Dial Transplant, 2009,24(2): 571-577.

共引文献35

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部